These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 25826710)

  • 1. Identifying Medication Targets for Psychostimulant Addiction: Unraveling the Dopamine D3 Receptor Hypothesis.
    Keck TM; John WS; Czoty PW; Nader MA; Newman AH
    J Med Chem; 2015 Jul; 58(14):5361-80. PubMed ID: 25826710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the dopamine D3 receptor: an overview of drug design strategies.
    Cortés A; Moreno E; Rodríguez-Ruiz M; Canela EI; Casadó V
    Expert Opin Drug Discov; 2016 Jul; 11(7):641-64. PubMed ID: 27135354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current Perspectives on Selective Dopamine D
    Newman AH; Xi ZX; Heidbreder C
    Curr Top Behav Neurosci; 2023; 60():157-201. PubMed ID: 35543868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medication discovery for addiction: translating the dopamine D3 receptor hypothesis.
    Newman AH; Blaylock BL; Nader MA; Bergman J; Sibley DR; Skolnick P
    Biochem Pharmacol; 2012 Oct; 84(7):882-90. PubMed ID: 22781742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuronal Dopamine D3 Receptors: Translational Implications for Preclinical Research and CNS Disorders.
    Kiss B; Laszlovszky I; Krámos B; Visegrády A; Bobok A; Lévay G; Lendvai B; Román V
    Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33466844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the transport, metabolism, and pharmacokinetics of the dopamine D3 receptor-selective fluorenyl- and 2-pyridylphenyl amides developed for treatment of psychostimulant abuse.
    Mason CW; Hassan HE; Kim KP; Cao J; Eddington ND; Newman AH; Voulalas PJ
    J Pharmacol Exp Ther; 2010 Jun; 333(3):854-64. PubMed ID: 20228156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine D3 and 5-HT1B receptor dysregulation as a result of psychostimulant intake and forced abstinence: Implications for medications development.
    Neisewander JL; Cheung TH; Pentkowski NS
    Neuropharmacology; 2014 Jan; 76 Pt B(0 0):301-19. PubMed ID: 23973315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective antagonism at dopamine D3 receptors as a target for drug addiction pharmacotherapy: a review of preclinical evidence.
    Heidbreder C
    CNS Neurol Disord Drug Targets; 2008 Nov; 7(5):410-21. PubMed ID: 19128200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current drug treatments targeting dopamine D3 receptor.
    Leggio GM; Bucolo C; Platania CB; Salomone S; Drago F
    Pharmacol Ther; 2016 Sep; 165():164-77. PubMed ID: 27343365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Affinity Dopamine D3 Receptor (D3R)-Selective Antagonists Attenuate Heroin Self-Administration in Wild-Type but not D3R Knockout Mice.
    Boateng CA; Bakare OM; Zhan J; Banala AK; Burzynski C; Pommier E; Keck TM; Donthamsetti P; Javitch JA; Rais R; Slusher BS; Xi ZX; Newman AH
    J Med Chem; 2015 Aug; 58(15):6195-213. PubMed ID: 26203768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine D3 receptor ligands for drug addiction treatment: update on recent findings.
    Le Foll B; Collo G; Rabiner EA; Boileau I; Merlo Pich E; Sokoloff P
    Prog Brain Res; 2014; 211():255-75. PubMed ID: 24968784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highly Selective Dopamine D3 Receptor (D3R) Antagonists and Partial Agonists Based on Eticlopride and the D3R Crystal Structure: New Leads for Opioid Dependence Treatment.
    Kumar V; Bonifazi A; Ellenberger MP; Keck TM; Pommier E; Rais R; Slusher BS; Gardner E; You ZB; Xi ZX; Newman AH
    J Med Chem; 2016 Aug; 59(16):7634-50. PubMed ID: 27508895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine D
    Gogarnoiu ES; Vogt CD; Sanchez J; Bonifazi A; Saab E; Shaik AB; Soler-Cedeño O; Bi GH; Klein B; Xi ZX; Lane JR; Newman AH
    J Med Chem; 2023 Feb; 66(3):1809-1834. PubMed ID: 36661568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine D3 receptor binding of (18)F-fallypride: Evaluation using in vitro and in vivo PET imaging studies.
    Mukherjee J; Constantinescu CC; Hoang AT; Jerjian T; Majji D; Pan ML
    Synapse; 2015 Dec; 69(12):577-91. PubMed ID: 26422464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of arylpiperazine-reverse amides as biased dopamine D3 receptor ligands.
    Cao Y; Paudel S; Zhang X; Kim KM; Cheon SH
    Bioorg Med Chem; 2015 Sep; 23(17):5264-72. PubMed ID: 26278029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and evaluation of bitopic arylpiperazinephenyl-1,2,4-oxadiazoles as preferential dopamine D3 receptor ligands.
    Cao Y; Min C; Acharya S; Kim KM; Cheon SH
    Bioorg Med Chem; 2016 Jan; 24(2):191-200. PubMed ID: 26707842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of dopamine D3 receptor in alleviating behavioural deficits in animal models of post-traumatic stress disorder.
    Song D; Ge Y; Chen Z; Shang C; Guo Y; Zhao T; Li Y; Wu N; Song R; Li J
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt A):190-200. PubMed ID: 29510167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A highly D
    Galaj E; Bi GH; Klein B; Hempel B; Shaik AB; Gogarnoiu ES; Friedman J; Lam J; Rais R; Reed JF; Bloom SH; Swanson TL; Schmachtenberg JL; Eshleman AJ; Janowsky A; Xi ZX; Newman AH
    Neuropsychopharmacology; 2022 Dec; 47(13):2309-2318. PubMed ID: 35879349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using click chemistry toward novel 1,2,3-triazole-linked dopamine D3 receptor ligands.
    Keck TM; Banala AK; Slack RD; Burzynski C; Bonifazi A; Okunola-Bakare OM; Moore M; Deschamps JR; Rais R; Slusher BS; Newman AH
    Bioorg Med Chem; 2015 Jul; 23(14):4000-12. PubMed ID: 25650314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine D4 receptors in psychostimulant addiction.
    Di Ciano P; Grandy DK; Le Foll B
    Adv Pharmacol; 2014; 69():301-21. PubMed ID: 24484981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.